
Razelle Kurzrock/froedtert.com
Feb 7, 2025, 14:14
The need for personalized, patient-centered, biomarker-based approaches to oncology clinical trials
CA: A Cancer Journal for Clinicians shared a post on X about a paper by Razelle Kurzrock et al. published in the Cancer Journal for Clinicians:
“Revisit the recently published Open Access review from Razelle Kurzrock and colleagues as they explore next-generation sequencing and the need for personalized, patient-centered, biomarker-based approaches to oncology clinical trials.”
“Novel clinical trial designs emerging from the molecular reclassification of cancer”
Authors: Mina Nikanjam, Shumei Kato, Teresa Allen, Jason Sicklick, Razelle Kurzrock.
More posts featuring CA: A Cancer Journal for Clinicians.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 13, 2025, 14:26
Mar 13, 2025, 10:43
Mar 13, 2025, 10:14
Mar 13, 2025, 10:06
Mar 13, 2025, 09:32
Mar 13, 2025, 09:10
Mar 13, 2025, 09:07
Mar 13, 2025, 08:55
Mar 13, 2025, 08:44